Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA

Journal of Immunology

Volumn 188, Issue 9, 2012, Pages 4421-4431

  Gu, Chunfang ^a   Jenkins, Sarah A ^a   Xue, Qiong ^a,b   Xu, Yi ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Yale University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; MEMBRANE PROTEIN; PROTEIN BCLA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIUM ADHERENCE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; MOUSE; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; WILD TYPE;

ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; BACILLUS ANTHRACIS; CELL LINE; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT PATHWAY, CLASSICAL; IMMUNOGLOBULIN G; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; SPORES, BACTERIAL;

EID: 84860337162     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102092     Document Type: Article

References (84)

1. Walport, M. J. 2001. Complement: second of two parts. N. Engl. J. Med. 344: 1140-1144.
2. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
3. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
4. Granoff, D. M., J. A. Welsch, and S. Ram. 2009. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect. Immun. 77: 764-769.
5. Seib, K. L., D. Serruto, F. Oriente, I. Delany, J. Adu-Bobie, D. Veggi, B. Aricò, R. Rappuoli, and M. Pizza. 2009. Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect. Immun. 77: 292-299.
6. Dunphy, K. Y., P. T. Beernink, B. Brogioni, and D. M. Granoff. 2011. Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood. Infect. Immun. 79: 353-359.
7. Findlow, J., R. Borrow, M. D. Snape, T. Dawson, A. Holland, T. M. John, A. Evans, K. L. Telford, E. Ypma, D. Toneatto, et al. 2010. Multicenter, openlabel, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51: 1127-1137.
8. Jiang, H. Q., S. K. Hoiseth, S. L. Harris, L. K. McNeil, D. Zhu, C. Tan, A. A. Scott, K. Alexander, K. Mason, L. Miller, et al. 2010. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28: 6086-6093.
9. Keiser, P. B., S. Biggs-Cicatelli, E. E. Moran, D. H. Schmiel, V. B. Pinto, R. E. Burden, L. B. Miller, J. E. Moon, R. A. Bowden, J. F. Cummings, and W. D. Zollinger. 2011. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 29: 1413-1420.
10. Snape, M. D., T. Dawson, P. Oster, A. Evans, T. M. John, B. Ohene-Kena, J. Findlow, L. M. Yu, R. Borrow, E. Ypma, et al. 2010. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr. Infect. Dis. J. 29: e71-e79.
11. Vu, D. M., T. T. Wong, and D. M. Granoff. 2011. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen. Vaccine 29: 1968-1973.
12. Lee, L. Y., X. Liang, M. Höök, and E. L. Brown. 2004. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). J. Biol. Chem. 279: 50710-50716. (Pubitemid 40017808)
13. Lee, L. Y., M. Höök, D. Haviland, R. A. Wetsel, E. O. Yonter, P. Syribeys, J. Vernachio, and E. L. Brown. 2004. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190: 571-579. (Pubitemid 38982098)
14. Langley, R., B. Wines, N. Willoughby, I. Basu, T. Proft, and J. D. Fraser. 2005. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J. Immunol. 174: 2926-2933. (Pubitemid 40279711)
15. Bestebroer, J., P. C. Aerts, S. H. Rooijakkers, M. K. Pandey, J. Köhl, J. A. van Strijp, and C. J. de Haas. 2010. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 12: 1506-1516.
16. Ricklin, D., A. Tzekou, B. L. Garcia, M. Hammel, W. J. McWhorter, G. Sfyroera, Y. Q. Wu, V. M. Holers, A. P. Herbert, P. N. Barlow, et al. 2009. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J. Immunol. 183: 2565-2574.
17. Garcia, B. L., A. Tzekou, K. X. Ramyar, W. J. McWhorter, D. Ricklin, J. D. Lambris, and B. V. Geisbrecht. 2009. Crystallization of human complement component C3b in the presence of a staphylococcal complement-inhibitor protein (SCIN). Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65: 482-485.
18. Jongerius, I., M. Puister, J. Wu, M. Ruyken, J. A. van Strijp, and S. H. Rooijakkers. 2010. Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases. J. Immunol. 184: 420-425.
19. Rooijakkers, S. H., J. Wu, M. Ruyken, R. van Domselaar, K. L. Planken, A. Tzekou, D. Ricklin, J. D. Lambris, B. J. Janssen, J. A. van Strijp, and P. Gros. 2009. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 10: 721-727.
20. Rooijakkers, S. H., F. J. Milder, B. W. Bardoel, M. Ruyken, J. A. van Strijp, and P. Gros. 2007. Staphylococcal complement inhibitor: structure and active sites. J. Immunol. 179: 2989-2998.
21. van Wamel, W. J., S. H. Rooijakkers, M. Ruyken, K. P. van Kessel, and J. A. van Strijp. 2006. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 188: 1310-1315. (Pubitemid 43228664)
22. Carroll, M. V., N. Lack, E. Sim, A. Krarup, and R. B. Sim. 2009. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol. Immunol. 46: 3367-3378.
23. Ferguson, J. S., J. J. Weis, J. L. Martin, and L. S. Schlesinger. 2004. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect. Immun. 72: 2564-2573. (Pubitemid 38542382)
24. Ramanathan, V. D., J. Curtis, and J. L. Turk. 1980. Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect. Immun. 29: 30-35. (Pubitemid 10085970)
25. Kojouharova, M. S., I. D. Panchev, M. I. Tchorbadjieva, K. B. Reid, and H. J. Hoppe. 1998. Differential binding of IgG and of a HIV gp41 peptide by the B chain and A chain globular head sequences of C1q, respectively. J. Immunol. 161: 4325-4331. (Pubitemid 28469017)
26. Ebenbichler, C. F., N. M. Thielens, R. Vornhagen, P. Marschang, G. J. Arlaud, and M. P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174: 1417-1424.
27. Guidi-Rontani, C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol. 10: 405-409. (Pubitemid 35246267)
28. Oliva, C., C. L. Turnbough, Jr., and J. F. Kearney. 2009. CD14-Mac-1 interactions in Bacillus anthracis spore internalization by macrophages. Proc. Natl. Acad. Sci. USA 106: 13957-13962.
29. Oliva, C. R., M. K. Swiecki, C. E. Griguer, M. W. Lisanby, D. C. Bullard, C. L. Turnbough, Jr., and J. F. Kearney. 2008. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl. Acad. Sci. USA 105: 1261-1266. (Pubitemid 351397041)
30. Cleret, A., A. Quesnel-Hellmann, A. Vallon-Eberhard, B. Verrier, S. Jung, D. Vidal, J. Mathieu, and J. N. Tournier. 2007. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 178: 7994-8001. (Pubitemid 46898070)
31. Shetron-Rama, L. M., A. C. Herring-Palmer, G. B. Huffnagle, and P. Hanna. 2010. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells. Microb. Pathog. 49: 38-46.
32. Tournier, J. N., and M. Mohamadzadeh. 2010. Key roles of dendritic cells in lung infection and improving anthrax vaccines. Trends Mol. Med. 16: 303-312.
33. Russell, B. H., Q. Liu, S. A. Jenkins, M. J. Tuvim, B. F. Dickey, and Y. Xu. 2008. In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells. Infect. Immun. 76: 3975-3983.
34. Xue, Q., S. A. Jenkins, C. Gu, E. Smeds, Q. Liu, R. Vasan, B. H. Russell, and Y. Xu. 2010. Bacillus anthracis spore entry into epithelial cells is an actindependent process requiring c-Src and PI3K. PLoS One 5: e11665.
35. Gut, I. M., B. Tamilselvam, A. M. Prouty, B. Stojkovic, S. Czeschin, W. A. van der Donk, and S. R. Blanke. 2011. Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro. BMC Microbiol. 11: 46.
36. Guidi-Rontani, C., M. Weber-Levy, E. Labruyère, and M. Mock. 1999. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31: 9-17. (Pubitemid 29012143)
37. Barua, S., M. McKevitt, K. DeGiusti, E. E. Hamm, J. Larabee, S. Shakir, K. Bryant, T. M. Koehler, S. R. Blanke, D. Dyer, et al. 2009. The mechanism of Bacillus anthracis intracellular germination requires multiple and highly diverse genetic loci. Infect. Immun. 77: 23-31.
38. Xue, Q., C. Gu, J. Rivera, M. Höök, X. Chen, A. Pozzi, and Y. Xu. 2011. Entry of Bacillus anthracis spores into epithelial cells is mediated by the spore surface protein BclA, integrin a2b1 and complement component C1q. Cell. Microbiol. 13: 620-634.
39. Russell, B. H., R. Vasan, D. R. Keene, and Y. Xu. 2007. Bacillus anthracis internalization by human fibroblasts and epithelial cells. Cell. Microbiol. 9: 1262-1274. (Pubitemid 46547143)
40. Boydston, J. A., P. Chen, C. T. Steichen, and C. L. Turnbough, Jr. 2005. Orientation within the exosporium and structural stability of the collagen-like glycoprotein BclA of Bacillus anthracis. J. Bacteriol. 187: 5310-5317. (Pubitemid 41022950)
41. Russell, B. H., R. Vasan, D. R. Keene, T. M. Koehler, and Y. Xu. 2008. Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cell. Microbiol. 10: 945-957. (Pubitemid 351386949)
42. Lu, J. H., B. K. Teh, L. Wang, Y. N. Wang, Y. S. Tan, M. C. Lai, and K. B. Reid. 2008. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell. Mol. Immunol. 5: 9-21.
43. Nayak, A., J. Ferluga, A. G. Tsolaki, and U. Kishore. 2010. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol. Lett. 131: 139-150.
44. Alvarez-Dominguez, C., E. Carrasco-Marin, and F. Leyva-Cobian. 1993. Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines. Infect. Immun. 61: 3664-3672. (Pubitemid 23260035)
45. Ogden, C. A., A. deCathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194: 781-795. (Pubitemid 32983014)
46. Roumenina, L. T., A. A. Kantardjiev, B. P. Atanasov, P. Waters, M. Gadjeva, K. B. Reid, A. Mantovani, U. Kishore, and M. S. Kojouharova. 2005. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q. Biochemistry 44: 14097-14109. (Pubitemid 41534668)
47. Stoiber, H., C. F. Ebenbichler, N. M. Thielens, G. J. Arlaud, and M. P. Dierich. 1995. HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120. Mol. Immunol. 32: 371-374.
48. Watford, W. T., A. J. Ghio, and J. R. Wright. 2000. Complement-mediated host defense in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L790-L798.
49. Merino, S., M. M. Nogueras, A. Aguilar, X. Rubires, S. Albertí, V. J. Benedí, and J. M. Tomás. 1998. Activation of the complement classical pathway (C1q binding) by mesophilic Aeromonas hydrophila outer membrane protein. Infect. Immun. 66: 3825-3831. (Pubitemid 28347843)
50. Merino, S., S. Vilches, R. Canals, S. Ramirez, and J. M. Tomás. 2005. A C1q-binding 40 kDa porin from Aeromonas salmonicida: cloning, sequencing, role in serum susceptibility and fish immunoprotection. Microb. Pathog. 38: 227-237. (Pubitemid 40733552)
51. Roumenina, L. T., K. T. Popov, S. V. Bureeva, M. Kojouharova, M. Gadjeva, S. Rabheru, R. Thakrar, A. Kaplun, and U. Kishore. 2008. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim. Biophys. Acta 1784: 1271-1276.
52. Fulop, M., T. Webber, and R. Manchee. 1993. Activation of the complement system by Francisella tularensis lipopolysaccharide. New Microbiol. 16: 141-147.
53. Loos, M., B. Euteneuer, and F. Clas. 1990. Interaction of bacterial endotoxin (LPS) with fluid phase and macrophage membrane associated C1Q: the FC-recognizing component of the complement system. Adv. Exp. Med. Biol. 256: 301-317. (Pubitemid 20244420)
54. Mintz, C. S., P. I. Arnold, W. Johnson, and D. R. Schultz. 1995. Antibodyindependent binding of complement component C1q by Legionella pneumophila. Infect. Immun. 63: 4939-4943.
55. Albertí, S., G. Marqués, S. Camprubí, S. Merino, J. M. Tomás, F. Vivanco, and V. J. Benedí. 1993. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun. 61: 852-860. (Pubitemid 23059640)
56. Aubert, B., S. Chesne, G. J. Arlaud, and M. G. Colomb. 1985. Antibodyindependent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem. J. 232: 513-519. (Pubitemid 16210786)
57. Stemmer, F., and M. Loos. 1985. Evidence for direct binding of the first component of complement, C1, to outer membrane proteins from Salmonella minnesota. Curr. Top. Microbiol. Immunol. 121: 73-84.
58. Butko, P., A. Nicholson-Weller, and M. R. Wessels. 1999. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J. Immunol. 163: 2761-2768. (Pubitemid 29399203)
59. Levy, N. J., and D. L. Kasper. 1985. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1. Infect. Immun. 49: 19-24. (Pubitemid 15062862)
60. Levy, N. J., and D. L. Kasper. 1986. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway. J. Immunol. 136: 4157-4162. (Pubitemid 16123065)
61. Hu, H., Q. Sa, T. M. Koehler, A. I. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell. Microbiol. 8: 1634-1642. (Pubitemid 44350022)
62. Guidi-Rontani, C., M. Levy, H. Ohayon, and M. Mock. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol. Microbiol. 42: 931-938. (Pubitemid 33078377)
63. Dixon, T. C., A. A. Fadl, T. M. Koehler, J. A. Swanson, and P. C. Hanna. 2000. Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cell. Microbiol. 2: 453-463. (Pubitemid 32049317)
64. Ireland, J. A., and P. C. Hanna. 2002. Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS. Infect. Immun. 70: 5870-5872.
65. Hu, H., J. Emerson, and A. I. Aronson. 2007. Factors involved in the germination and inactivation of Bacillus anthracis spores in murine primary macrophages. FEMS Microbiol. Lett. 272: 245-250. (Pubitemid 47074612)
66. Weiner, M. A., and P. C. Hanna. 2003. Macrophage-mediated germination of Bacillus anthracis endospores requires the gerH operon. Infect. Immun. 71: 3954-3959. (Pubitemid 36753720)
67. Heffernan, B. J., B. Thomason, A. Herring-Palmer, L. Shaughnessy, R. McDonald, N. Fisher, G. B. Huffnagle, and P. Hanna. 2006. Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infect. Immun. 74: 3756-3764. (Pubitemid 43993306)
68. Ramarao, N., and D. Lereclus. 2005. The InhA1 metalloprotease allows spores of the B. cereus group to escape macrophages. Cell. Microbiol. 7: 1357-1364. (Pubitemid 41179427)
69. Heffernan, B. J., B. Thomason, A. Herring-Palmer, and P. Hanna. 2007. Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax. FEMS Microbiol. Lett. 271: 98-105. (Pubitemid 46701071)
70. Mosser, E. M., and R. F. Rest. 2006. The Bacillus anthracis cholesteroldependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages. BMC Microbiol. 6: 56.
71. Wei, Z., P. Schnupf, M. A. Poussin, L. A. Zenewicz, H. Shen, and H. Goldfine. 2005. Characterization of Listeria monocytogenes expressing anthrolysin O and phosphatidylinositol-specific phospholipase C from Bacillus anthracis. Infect. Immun. 73: 6639-6646. (Pubitemid 41368829)
72. Pomerantsev, A. P., K. V. Kalnin, M. Osorio, and S. H. Leppla. 2003. Phosphatidylcholine-specific phospholipase C and sphingomyelinase activities in bacteria of the Bacillus cereus group. Infect. Immun. 71: 6591-6606. (Pubitemid 37337719)
73. Réty, S., S. Salamitou, I. Garcia-Verdugo, D. J. S. Hulmes, F. Le Hégarat, R. Chaby, and A. Lewit-Bentley. 2005. The crystal structure of the Bacillus anthracis spore surface protein BclA shows remarkable similarity to mammalian proteins. J. Biol. Chem. 280: 43073-43078. (Pubitemid 43049273)
74. Ghai, R., P. Waters, L. T. Roumenina, M. Gadjeva, M. S. Kojouharova, K. B. Reid, R. B. Sim, and U. Kishore. 2007. C1q and its growing family. Immunobiology 212: 253-266. (Pubitemid 46830353)
75. Daubenspeck, J. M., H. Zeng, P. Chen, S. Dong, C. T. Steichen, N. R. Krishna, D. G. Pritchard, and C. L. Turnbough, Jr. 2004. Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J. Biol. Chem. 279: 3045-30953.
76. Xu, Y., D. R. Keene, J. M. Bujnicki, M. Höök, and S. Lukomski. 2002. Streptococcal Scl1 and Scl2 proteins form collagen-like triple helices. J. Biol. Chem. 277: 27312-27318. (Pubitemid 34951750)
77. Lukomski, S., K. Nakashima, I. Abdi, V. J. Cipriano, R. M. Ireland, S. D. Reid, G. G. Adams, and J. M. Musser. 2000. Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect. Immun. 68: 6542-6553. (Pubitemid 32463352)
78. Paterson, G. K., L. Nieminen, J. M. Jefferies, and T. J. Mitchell. 2008. PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells. FEMS Microbiol. Lett. 285: 170-176. (Pubitemid 352000227)
79. Caswell, C. C., E. Lukomska, N. S. Seo, M. Höök, and S. Lukomski. 2007. Scl1-dependent internalization of group A Streptococcus via direct interactions with the alpha2beta(1) integrin enhances pathogen survival and re-emergence. Mol. Microbiol. 64: 1319-1331. (Pubitemid 46849020)
80. Han, R., C. C. Caswell, E. Lukomska, D. R. Keene, M. Pawlowski, J. M. Bujnicki, J. K. Kim, and S. Lukomski. 2006. Binding of the low-density lipoprotein by streptococcal collagen-like protein Scl1 of Streptococcus pyogenes. Mol. Microbiol. 61: 351-367. (Pubitemid 44356568)
81. Reuter, M., C. C. Caswell, S. Lukomski, and P. F. Zipfel. 2010. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagenlike protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J. Biol. Chem. 285: 38473-38485.
82. Bozue, J., C. K. Cote, K. L. Moody, and S. L. Welkos. 2007. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Infect. Immun. 75: 508-511. (Pubitemid 46047928)
83. Harvill, E. T., G. Lee, V. K. Grippe, and T. J. Merkel. 2005. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect. Immun. 73: 4420-4422. (Pubitemid 40923192)
84. Welkos, S. L., T. J. Keener, and P. H. Gibbs. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51: 795-800. (Pubitemid 16162978)